169
Participants
Start Date
July 14, 2016
Primary Completion Date
March 15, 2018
Study Completion Date
May 22, 2018
Setipiprant
Setipiprant tablets, orally, BID for 24 weeks.
Placebo
Placebo tablets, orally, BID for 24 weeks.
Finasteride
Finasteride tablet, orally, once daily for 24 weeks.
Penn State Hershey Medical Center Dermatology Research Office, Hershey
The Education & Research Foundation, Inc, Lynchburg
Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard, Winston-Salem
Radiant Research, Inc., Greer
Cleveland Clinic, Dept of Dermatology, Cleveland
Michigan Center for Skin Care Research, Clinton Township
Minnesota Clinical Study Center, Fridley
University of Minnesota Department of Dermatology Division of Clinical research, Minneapolis
DeNova Research, Chicago
Heartland Research Associates, LLC, Wichita
Burke Pharmaceutical Research, Hot Springs
Petrus Center for Aesthetic Surgery & Hair Transplantation, Little Rock
Suzzane Bruce and Associates P.A., The Center for Skin Research, Katy
DermResearch, Inc, Austin
Therapeutics Clinical Research, San Diego
Radiant Research, Inc., Santa Rosa
NW Dermatology and Research Center, Portland
Oregon Medical Research Center, Portland
Lead Sponsor
Allergan
INDUSTRY